Pfizer, Bristol clot drug wins EU green light for wider use

June 27, 2014 11:36 AM

10 0

Pfizer, Bristol clot drug wins EU green light for wider use

LONDON (Reuters) - Pfizer and Bristol-Myers Squibb's oral anticoagulant Eliquis has been recommended for wider use in Europe, boosting prospects for an important drug to both U.S. companies.

European Medicines Agency (EMA) experts recommended that Eliquis, also known as apixaban, should be approved for treating deep vein thrombosis and pulmonary embolism, as well as for preventing recurrent cases, the drugmakers said on Friday.

Read more

To category page

Loading...